Triple therapy to help fight deadly lung cancer

Washington, Jan 1 (IANS) In experimental models of lung cancer, researchers have found that a combination of two drugs plus radiation can help treat resistant lung cancers which are susceptible to therapy.

Although the most common type of lung cancer – non-small cell lung cancer (NSCLC) – has recently seen major treatment advances, other subtypes continue to evade effective treatment.

Now, a new study in mice has shown that cancers with mutations in the gene known as KRAS may benefit from a triple therapy with two experimental drugs plus radiation therapy.

“Currently there is a clinical trial underway to evaluate the combination of two cancer drugs made by two pharma companies for patients with solid tumors and melanoma,” claimed Bo Lu, professor of radiation oncology at Thomas Jefferson University.

“Our study suggests that we may be able to identify non-small cell lung cancer patients who are likely to benefit most from this combination of therapies,” he added.

Roughly 85 percent of all lung cancers belong to the NSCLC type.

Although there have been some advances in treating this disease, only two percent of survivors live five years beyond treatment.

The researchers combined the KRAS-targeting drug with another drug.

Together, Dr Lu’s group showed that the combination of the two drugs make these resistant cancer cells susceptible to radiation treatment.

“If you hit one target another can take over. If you hit two, it becomes a lethal bullet,” Dr Lu added.

Dr Lu hopes that this research will help identify the patients who could potentially benefit from a triple-therapy treatment.

The results were published in the journal Clinical Cancer Research.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here